StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > GETTING RIDICULOUS

<< Previous

Bullboard Posts

Next >>

Post by capebretongirlon Feb 23, 2021 10:08am

98 Views

Post# 32635899

GETTING RIDICULOUS

Ok, down 11% yesterday, down 11% again right now - the silent strategy from management is clearly not working. We were told by Tripp last year that we could expect more updates and connectivity with shareholders - where is it? If Aristotle is to come out in Q1, the pre package of marketing strategy/covid update/collaberations/large workplace employer/potential health insurers etc. etc. etc. etc. etc. should have been out a long time ago. Is this criticism of management on this vital point - YOU BET IT IS!!

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"